The benefit of everolimus in recurrent/epithelioid angiosarcoma patients: Case reports and literature review

Epithelioid angiosarcoma (EA) is a kind of rare malignant soft tissue sarcoma, with high recurrence/metastatic rate and poor prognosis. To date, no effective standardized treatment regimen has been available for patients with recurrence/metastatic EA. Everolimus is an oral rapamycin derivative that...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shi-Long, Liang, Li, Ji, Yuan, Wang, Zhi-Ming, Zhou, Yu-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706933/
https://www.ncbi.nlm.nih.gov/pubmed/29212287
http://dx.doi.org/10.18632/oncotarget.21832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706933/
https://www.ncbi.nlm.nih.gov/pubmed/29212287
http://dx.doi.org/10.18632/oncotarget.21832

Ejemplares similares